DPP4 and type 2 diabetes mellitus: Previous research has reported that isoquercitrin improved the type 2 diabetes by preventing the inactivation of glucagonlike peptide-1 (GLP-1) as a dipeptidyl peptidase-IV(DPP-IV) inhibitor [10].